Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Cardiogenic Shock Clinical Trial
NCT02754193 | Interventional

Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 334 Participants

A multicenter, prospective, controlled, randomized (moderate hypothermia 33°C≤ T°C ≤34°C) during 24 hours ± 1h versus normothermia (36°C≤ T°C ≤37°C), comparative open trial will be conducted on two parallel groups of patients with cardiogenic shock treated with VA-ECMO. The HYPO-ECMO trial will test the hypothesis that moderate hypothermia (temperature between 33°C≤ T°C ≤34°C) associated with VA-ECMO support results in a reduction in 30-day mortality in comparison with the normothermia group (36°C≤ T°C ≤37°C).